Menu
Press Releases

Press Releases

Search Press Releases
  
Subscribe for Email Alerts
7/17/2019
12:14 AM ET
Press Release

Repligen Corporation Announces Pricing of Public Offerings of $120 million of Common Stock and $250 million of 0.375% Convertible Senior Notes due 2024

7/17/2019

WALTHAM, Mass., July 17, 2019 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ: RGEN) (“Repligen”) today announced the pricing of concurrent underwritten public offerings of 1,380,000 shares of its...

 Continue Reading
7/15/2019
4:02 PM ET
Press Release

Repligen Corporation Announces Proposed Public Offerings of $100 million of Common Stock and $250 million of Convertible Senior Notes

7/15/2019

WALTHAM, Mass., July 15, 2019 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ: RGEN) (“Repligen”) today announced that it has commenced concurrent underwritten public offerings of $100,000,000 in s...

 Continue Reading
6/4/2019
10:03 AM ET
Press Release

Repligen to Present at Jefferies 2019 Healthcare Conference

6/4/2019

WALTHAM, Mass., June 04, 2019 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that Jon K. Snodgres, Ch...

 Continue Reading
5/9/2019
7:30 AM ET
Earnings Release

Repligen Reports First Quarter 2019 Financial Results and Updates Full Year 2019 Financial Guidance

5/9/2019

Reports first quarter revenue of $60.6 million, representing 35% year-over-year growth and 37% organic growthRaises revenue guidance to $235-$241 million for full year 2019, representing 22%-25% organ...

 Continue Reading
5/2/2019
2:20 PM ET
Press Release

Repligen to Report First Quarter 2019 Financial Results

5/2/2019

WALTHAM, Mass., May 02, 2019 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its first quarter 2019 financial results on Thursday, May 9, 2019. Th...

 Continue Reading
Displaying 1 to 5 (of 232 releases)